The efficacy and safety of novel oral anticoagulants for the preventive treatment in atrial fibrillation patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The efficacy and safety of novel oral anticoagulants for the preventive treatment in atrial fibrillation patients: a systematic review and meta-analysis

Published:2014-01-08 Issue:6 Volume:21 Page:436-452
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Liu Guang Jian,Wang Yun Fu,Chen Ping You,Chang Wei,Tu Ming Li,Chang Li Ying,Cheng Ping,Luo Jie

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10717544.2013.873500

Reference49 articles.

1. Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

2. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

3. Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

4. Prognostic factors in non-surgically treated sciatica: A systematic review

5. Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittent theta burst stimulation for poststroke non-spatial attention deficit: a protocol of prospective, double-blinded, single-centre, randomised controlled trial in China;BMJ Open;2023-10

2. Can we collect health-related quality of life information from anticoagulated atrial fibrillation participants who have recently experienced a bleed? An observational feasibility study in primary and secondary care in Wales and through a UK online forum;BMJ Open;2023-10

3. Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials;European Journal of Epidemiology;2016-06

4. Efficacy and safety of novel anticoagulants in the elderly;J GERIATR CARDIOL;2016

5. Thrombolytic Action of Apixaban on Intra-Atrial Thrombus Developed after Previous Treatment with Warfarin: A Case Report;Medical Principles and Practice;2016